Explore the latest in ovarian cancer, including recent advances in epidemiology, screening, genetic testing, and management of the disease.
This cohort study compares the outcomes of patients with BRCA1 and BRCA-related pancreatic cancers using 2 large data sets.
This comparative effectiveness cohort study evaluates the safety and effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) compared with interval cytoreductive surgery alone in clinical practice for patients with advanced-stage ovarian cancer.
This systematic review examines the development, outcomes, barriers, and future directives of bilateral salpingectomy for ovarian cancer prevention.
This randomized clinical trial evaluates whether eliminating pretest and/or posttest counseling for home-delivered cancer risk assessment is noninferior with regard to participant distress.
In this essay, the author grapples with the possibility of a diagnosis of BRCA2.
This cohort study assesses the prognostic outcomes of prophylactic salpingo-oophorectomy after surgical resection of breast cancer for patients carrying the BRCA1 or BRCA2 variant.
This pre/post interventional study assesses the ability of a preoperative risk stratification algorithm to identify lesions with a high likelihood of benign pathology that are appropriate for ovary-sparing surgery among pediatric patients with an ovarian mass.
This randomized clinical trial examines the efficacy and safety of treatment with niraparib with an individualized starting dose in Chinese patients with newly diagnosed advanced ovarian cancer.
This cohort study assesses the association between salpingectomy and the risk of invasive epithelial ovarian, fallopian tube, and peritoneal cancer among women in Ontario.
This cohort study examines data from randomized clinical trials on mean survival time and relative risk of progression of ovarian cancer with use of bevacizumab.
This cohort study examines the gender-specific COVID-19 case fatality risks among patients with a malignant neoplasm.
This secondary analysis compared the effect of a 6-month aerobic exercise intervention vs attention control for chemotherapy-induced peripheral neuropathy (CIPN) among participants in the Women’s Activity and Lifestyle Study in Connecticut trial who received chemotherapy for ovarian cancer.
This cross-sectional study describes the landscape of germline variants in gynecologic cancers and explores their association with somatic phenotypes and cancer risk.
This diagnostic study evaluates the performance of 3 ultrasonography-based risk models for differentiating between benign and malignant adnexal lesions in a US cohort.
This observational study describes the prevalence of germline genetic testing in California and Georgia between 2013 and 2019 among patients diagnosed with cancer.
This nonrandomized phase 2 clinical trial examines the clinical activity of Olvi-Vec oncolytic immunotherapy and subsequent platinum-doublet chemotherapy with or without bevacizumab in women with platinum-resistant or -refractory ovarian cancers.
This Viewpoint explains the use of opportunistic salpingectomy, removal of the fallopian tubes for the primary prevention of ovarian cancer in a woman already undergoing pelvic surgery for another indication.
This retrospective cohort study assesses mortality and survival in premenopausal women with pregnancy-associated cancers, with a particular focus on cancers other than those of the breast.
This review summarizes the current and evolving treatment landscape for platinum-resistant ovarian cancer and highlights the development of promising novel compounds.
Customize your JAMA Network experience by selecting one or more topics from the list below.